What top creators are saying about Novavax, Inc.(NVAX)

Biotechnology company developing vaccines.

3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 2 scored insights about Novavax, Inc..

Mixed
avg +0.00
0 bullish2 neutral0 bearish

Top creators covering Novavax, Inc. (NVAX)

The 3 sources with the most insights about Novavax, Inc. on Kazuha.

Latest insights about Novavax, Inc. (NVAX)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Wednesday, November 11, 2026

Neutral

The stock was called “crazy,” but no explanation or actionable investment view was provided.

Wednesday, November 4, 2026

Neutral

Novavax is mentioned as a maker of a spike-protein-targeting COVID-19 vaccine, but the discussion provides little company-specific investment insight.

Tuesday, October 6, 2026

Neutral

Mentioned in passing without specific investment analysis or a price target.

Discussed alongside Novavax, Inc. (NVAX)

Other assets that creators frequently mention in the same content as Novavax, Inc..

Frequently asked

Which podcasters and creators cover Novavax, Inc. (NVAX) the most?

The most active sources covering Novavax, Inc. (NVAX) on Kazuha are @amitinvesting, @theshkrelipill, Joe Rogan. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Novavax, Inc. (NVAX) are on Kazuha?

Kazuha has indexed 3 AI-extracted insights about Novavax, Inc. (NVAX) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Novavax, Inc. (NVAX)?

Creators covering Novavax, Inc. (NVAX) most frequently also discuss MRNA, GEV, NVDA, GOOGL, AMD. See the "Discussed alongside" section above for full asset pages.